NLRP3 and bronchopulmonary dysplasia: In a mouse model of bronchopulmonary dysplasia, tert-butylhydroquinone (TBHQ), an Nrf2 activator, mitigates pyroptosis and enhances alveolar development by reducing NLRP3 inflammasome activation and oxidative stress [35].